Hypersensitivity to the active substances, peanut, soya or to any of the excipients listed in Description (see also Precautions).
Known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen.
Active liver disease or unexplained persistent elevations of serum transaminases.
Known gallbladder disease.
Chronic or acute pancreatitis with the exception of acute pancreatitis due to severe hypertriglyceridaemia.
Moderate to severe renal insufficiency (estimated glomerular filtration rate < 60 mL/min/1.73 m2).
Concomitant administration of potent CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, HIV protease inhibitors, boceprevir, telaprevir, erythromycin, clarithromycin, telithromycin and nefazodone) (see Interactions).
Concomitant administration of gemfibrozil, ciclosporine, or danazol (see Interactions).
Concomitant administration of glecaprevir/pibrentasvir (see Interactions).
Paediatric population (age below 18 years).
Pregnancy and breast-feeding (see Use in Pregnancy & Lactation).
Personal history of myopathy and/or rhabdomyolysis with statins and/or fibrates or confirmed creatine phosphokinase elevation above 5 times the upper limit of normal (ULN) under previous statin treatment (see Precautions).